Drugs / montmorillonite
montmorillonite
also known as
Diosmectite · Smecta · Gelwhite gp · Gelwhite h · Gelwhite l · Montmorillonite clay · Smecdral
Trials 6 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT03045926 | Aug 2016 → May 2017 | functional diarrhea | Ipsen | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT02323516 | Dec 2014 → Dec 2015 | cancer | Centre Francois Baclesse | Withdrawn | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT04736186 | May 2020 → Oct 2022 | breast cancer | Tianjin Medical University Cancer Institute and Hospital | Unknown | No outcome recorded |
| Phase 32 trials | ||||||
| Phase 3 | NCT00352989 | Jul 2006 → Mar 2007 | acute diarrhea | Ipsen | Completed | No outcome recorded |
| Phase 3 | NCT00352716 | Jun 2006 → Feb 2007 | acute diarrhea | Ipsen | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT00276328 | Jan 2005 → Jul 2006 | diarrheal disease | Ipsen | Completed | No outcome recorded |
Also used as a comparator or background therapy in 4 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT06588036 Comparator | Sep → Dec 2024 overdue | — | Combined Military Hospital Multan | Not yet recruiting | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT02354768 Background | Oct 2015 → Dec 2017 | — | University Hospital, Strasbourg, France | Terminated | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT04788485 Comparator | Sep 2017 → Feb 2021 | gastroesophageal reflux disease | Ain Shams Maternity Hospital | Completed | No outcome recorded |
| Phase 4 | NCT02704091 Comparator | Mar 2016 → Apr 2019 | acute diarrhea | Ipsen | Completed | No outcome recorded |
Evidence & citations 9 cited values
Every value below carries the sentence it was read from. 12 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | montmorillonite | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04736186 ↗ |
| Known as | Diosmectite | “Efficacy of Diosmectite (Smecta®) in the Symptomatic Treatment of Acute Diarrhoea in Adults” NCT02704091 ↗ |
| Known as | Gelwhite gp | ChEMBL registry synonym — accepted as the source's own label CHEMBL4298106 ↗ |
| Known as | Gelwhite h | ChEMBL registry synonym — accepted as the source's own label CHEMBL4298106 ↗ |
| Known as | Gelwhite l | ChEMBL registry synonym — accepted as the source's own label CHEMBL4298106 ↗ |
| Known as | Montmorillonite clay | ChEMBL registry synonym — accepted as the source's own label CHEMBL4298106 ↗ |
| Known as | Smecdral | ChEMBL registry synonym — accepted as the source's own label CHEMBL4298106 ↗ |
| Known as | Smecta | “Efficacy of Diosmectite (Smecta®) in the Symptomatic Treatment of Acute Diarrhoea in Adults” NCT02704091 ↗4“Smecta (Diosmectite), duration of treatment - 7 days” NCT00352716 ↗ “Diosmectite (Smecta®)” NCT03045926 ↗ “Diosmectite (Smecta®)” NCT00276328 ↗ |
| Modality | Other / unclassified | “Diosmectite, a natural colloidal clay” PMID 35151268 ↗ Feb 2022 |